Ecolab Life Sciences Opens Bioprocessing Applications Lab in Korea to Support Downstream Process Development Across Asia

New facility serves biopharma manufacturers throughout the region with local access to customer purification studies across Ecolab's Purolite Resin portfolio

29 April 2026 -- Seoul, South Korea -- Ecolab Life Sciences is expanding the bioprocessing business with the launch of a new Bioprocessing Applications Lab (BPAL) in Dongtan, Korea, giving biopharmaceutical manufacturers across Asia better local access to downstream process development support. Strategically located to serve customers throughout the region, the site is Ecolab's first bioprocessing facility in Asia and joins an established applications network in the United States and the United Kingdom.

BPAL Korea supports process development from early-stage resin screening through studies designed to replicate commercial manufacturing conditions. On-site scientists work alongside customers across Asia to help optimize chromatography steps, improve yield and productivity, and accelerate regulatory pathways, reducing the need to ship resins and reference materials overseas for development work.

Asia has become one of the world's most active biopharmaceutical manufacturing regions, with Korea, China, Japan, India, and Singapore all home to growing pipelines in biosimilars and monoclonal antibody processes that demand efficient, scalable downstream purification. With local technical support now in place, manufacturers across the region can shorten development cycles and maintain consistency with global operations while working to tight regulatory and cost targets.

"Biopharmaceutical manufacturers across Asia are under increasing pressure to scale with speed while meeting demanding regulatory and performance expectations," said Jenny Tan, vice president and general manager, Ecolab Life Sciences APAC and India. "BPAL Korea strengthens our ability to work side by side with customers, bringing deep local expertise together with Ecolab's global, integrated bioprocessing network."

By combining local scientific support with Ecolab’s innovative Purolite™ resin portfolio, Ecolab’s new BPAL helps enable manufacturers to address process challenges earlier, reduce development risk, and advance programmes with greater confidence as they prepare for scale-up.

To learn more about Ecolab Life Sciences' bioprocessing development capabilities and how BPAL Korea supports scalable, regulatory-ready purification processes for customers across Asia, visit the Purolite Resins website here.

About Ecolab
A trusted partner for millions of customers, Ecolab is a global leader in water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. For more than a century, Ecolab has advanced innovation by integrating science-based solutions, data-driven insights, AI technology and world-class service. This unique combination enables Ecolab to partner with customers to define what best-in-class looks like and scale it across their operations, helping them achieve peak performance. Today, Ecolab delivers $16 billion in annual sales, employs 48,000 associates and serves customers in more than 170 countries and 40 industries. The company helps protect one-third of the world’s food production and a quarter of the power generated while delivering innovative solutions across food, hospitality, healthcare, data centers, microelectronics and life sciences. As the world’s water company, Ecolab plays an important role in AI growth by supporting the full water needs of advanced computing—from ultra‑pure water for chip manufacturing, to water solutions that support the power behind AI, to direct liquid cooling systems for high‑density computing that improves performance while reducing environmental impact through circular water use. In life sciences, Ecolab delivers end to end solutions that support the development and manufacturing of life-saving drugs, helping customers operate safely and consistently at scale while improving performance and reducing environmental impact. Through its comprehensive approach, Ecolab protects what’s vital, with a goal by 2030 to help protect 2 billion people from infections and conserve enough drinking water for 1 billion people, while continuing to enhance business performance.
Ecolab. Protecting What’s Vital. Visit: www.ecolab.com.